Aeglea BioTherapeutics Appoints Jim Kastenmayer as General Counsel
AUSTIN, Texas, July 15, 2021 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeu…
More from Central Texas
Mary Hardin–Baylor Crusaders
Women's Golf in First after round one of the Golfweek October Classic
Central Texas
•
1h ago
KWHI Radio Brenham Sports
FIELD GOAL TROUBLE CAUSES BLINN FOOTBALL TO LOSE TO CISCO IN 2-OT
Central Texas
•
3h ago
Killeen Daily Herald
Killeen ISD projects create new opportunities for Central Texas contractors
Central Texas
•
3h ago
Killeen Daily Herald
More than 600 turn out for Killeen NAACP's 15th annual breast cancer walk
Central Texas
•
3h ago
Killeen Daily Herald
CTC HVAC program sees record enrollment following instructional changes
Central Texas
•
6h ago
